Sectors
HBIO
Harvard Bioscience, Inc.
8.11
2 x 5.80
2 x 10.18
bid
ask
+
0.18
2.27%
2 @ 07:30 PM
8.11 +0.00 (0.00%)
| Ytd | 21.04% | |
| 1y | 62.20% |
7.92
day range
8.11
3.80
52 week range
9.40
| Open | 7.92 | Prev Close | 7.93 | Low | 7.92 | High | 8.11 | Mkt Cap | 36.92M |
| Vol | 32.33K | Avg Vol | 18.56K | EPS | -2.31 | P/E | N/A | Forward P/E | 14.00 |
| Beta | 1.31 | Short Ratio | 2.66 | Inst. Own | 75.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 6.42 | 200-d Avg | 6.15 | 1yr Est | 6.25 |
| Income Statement | |||
| Total Revenue | 22.73M | ||
| Revenues (USD) | 22.73M | ||
| Cost of Revenue | 10.10M | ||
| Gross Profit | 12.63M | ||
| Operating Expenses | 13.61M | ||
| Research and Development Expense | 2.45M | ||
| Selling, General and Administrative Expense | 10.02M | ||
| Operating Income | -978.00K | ||
| Interest Expense | 1.79M | ||
| Income Tax Expense | 14.00K | ||
| Net Income | -2.91M | ||
| Net Income Common Stock | -2.91M | ||
| Net Income Common Stock (USD) | -2.91M | ||
| Consolidated Income | -2.91M | ||
| Earnings per Basic Share | -0.64 | ||
| Earnings per Basic Share (USD) | -0.64 | ||
| Earnings per Diluted Share | -0.64 | ||
| Earning Before Interest & Taxes (EBIT) | -1.10M | ||
| Earning Before Interest & Taxes (USD) | -1.10M | ||
| Weighted Average Shares | 4.53M | ||
| Weighted Average Shares Diluted | 4.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.50M | ||
| Cash and Equivalents (USD) | 6.50M | ||
| Trade and Non-Trade Receivables | 14.50M | ||
| Current Assets | 46.46M | ||
| Property, Plant & Equipment Net | 11.75M | ||
| Total Assets | 76.29M | ||
| Total Debt | 42.61M | ||
| Current Liabilities | 24.79M | ||
| Debt Non-Current | 42.61M | ||
| Total Liabilities | 68.87M | ||
| Accumulated Retained Earnings (Deficit) | -221.04M | ||
| Accumulated Other Comprehensive Income | -12.37M | ||
| Shareholders Equity | 7.42M | ||
| Shareholders Equity (USD) | 7.42M | ||
| Assets Non-Current | 29.82M | ||
| Total Debt (USD) | 42.61M | ||
| Deferred Revenue | 3.60M | ||
| Goodwill and Intangible Assets | 15.55M | ||
| Inventory | 22.23M | ||
| Liabilities Non-Current | 44.08M | ||
| Trade and Non-Trade Payables | 6.22M | ||
| Tax Liabilities | 311.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.38M | ||
| Net Cash Flow from Financing | -38.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -595.00K | ||
| Capital Expenditure | -916.00K | ||
| Issuance (Repayment) of Debt Securities | -2.00K | ||
| Net Cash Flow from Investing | -916.00K | ||
| Net Cash Flow from Operations | 325.00K | ||
| Effect of Exchange Rate Changes on Cash | 34.00K | ||
| Share Based Compensation | 380.00K | ||